| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 24.009 | 22.384 | 18.804 | 11.149 | 23.370 | 4.734 | 2.082 | 13.750 | 15.342 | 17.407 |
| Total Income - EUR | 24.009 | 22.718 | 18.804 | 11.579 | 30.925 | 4.734 | 2.082 | 13.750 | 16.147 | 17.407 |
| Total Expenses - EUR | 17.813 | 17.611 | 16.292 | 9.923 | 18.287 | 12.329 | 10.611 | 15.741 | 20.632 | 19.834 |
| Gross Profit/Loss - EUR | 6.196 | 5.107 | 2.513 | 1.656 | 12.639 | -7.595 | -8.529 | -1.990 | -4.485 | -2.426 |
| Net Profit/Loss - EUR | 5.475 | 4.880 | 1.960 | 1.348 | 12.118 | -7.637 | -8.591 | -2.403 | -4.647 | -2.985 |
| Employees | 4 | 5 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 |
Check the financial reports for the company - Supermed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 234 | 10.988 | 7.496 | 4.546 | 29.372 | 22.828 | 16.479 | 10.695 | 4.847 | 0 |
| Current Assets | 4.534 | 2.434 | 2.186 | 1.169 | 5.106 | 657 | 408 | 1.003 | 1.567 | 274 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 245 | 242 | 236 | 232 | 228 | 223 | 218 | 219 | 0 | 0 |
| Cash | 4.289 | 2.192 | 1.950 | 936 | 4.878 | 434 | 189 | 784 | 1.567 | 274 |
| Shareholders Funds | -1.390 | 3.504 | 2.065 | 1.451 | 12.219 | 4.350 | -4.338 | -6.754 | -11.380 | -14.301 |
| Social Capital | 90 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 6.158 | 9.919 | 7.617 | 4.263 | 22.259 | 19.134 | 21.224 | 18.451 | 17.794 | 14.575 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Supermed S.r.l.